Results 231 to 240 of about 143,581 (292)

Does Combined Intravenous and Topical Tranexamic Acid Offer Additional Benefit Compared With Intravenous or Topical Alone in Open Elbow Arthrolysis—A Pilot Randomized Controlled Trial

open access: yesOrthopaedic Surgery, EarlyView.
Open elbow arthrolysis is a common method for treating post‐traumatic elbow stiffness. Intravenous, topical, or combined tranexamic acid administration showed no significant difference in reducing postoperative blood loss after open elbow arthrolysis. However, both combined and topical tranexamic acid significantly reduced postoperative drainage volume
Chen Chen   +7 more
wiley   +1 more source

Pharmacomechanical catheter-directed thrombolysis for deep-vein thrombosis [PDF]

open access: yes, 2017
Blinder, M.   +7 more
core   +1 more source

Interplay of Probe Stability and Oscillation During Very‐High‐Power Short‐Duration Ablation in Pulmonary Vein Isolation for Atrial Fibrillation

open access: yesPacing and Clinical Electrophysiology, EarlyView.
This graphical abstract presents a comprehensive analysis of probe stability and oscillation during very high‐power short‐duration (vHPSD) pulmonary vein isolation (PVI) for atrial fibrillation. The findings indicate that oscillation velocity serves as a more reliable predictor of impedance drop and temperature changes than contact force alone ...
Ernesto Cristiano   +7 more
wiley   +1 more source

The role of neutrophils in the pathophysiology of inflammatory bowel diseases

open access: yesPeriodontology 2000, EarlyView.
Abstract Objectives Inflammatory bowel disease (IBD) encompasses a spectrum of chronic disorders of the gastrointestinal tract, with a potential bidirectional relationship with periodontitis. Neutrophils are key regulators of immune‐inflammatory responses and play a major role in both diseases.
Joao Paulo Steffens   +8 more
wiley   +1 more source

Implantation of a leadless pacemaker in a pediatric patient with congenital heart disease. [PDF]

open access: yes, 2018
Batra, Anjan S   +5 more
core  

Comparative 3‐Year Allograft Outcomes for Recipients of Kidneys From SARS‐CoV‐2 NAT‐Positive Donors

open access: yesTransplant Infectious Disease, EarlyView.
In this retrospective single‐center study of 220 kidney transplants from SARS‐CoV‐2 NAT+, NAT+ with COVID as cause of death (CoV‐COD) and NATneg donors, we found no significant difference in rejection or kidney pathologies at 1 year, and death, graft loss, or eGFR at 3 years by CoV‐donor status.
Christine E. Koval   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy